Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China
Highly active antiretroviral therapy (HAART) has been able to improve the immune system function and survival of human immunodeficiency virus (HIV) patients. However, Patients coinfected with HIV and hepatitis... (Source: BMC Infectious Diseases)
Source: BMC Infectious Diseases - April 8, 2024 Category: Infectious Diseases Authors: Jianxin Tang, Ruihui Weng, Taishi Fang, Kangjun Zhang, Xu Yan, Xin Jin, Linjie Xie and Dong Zhao Tags: Research Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Analysis of clinical characteristics of persistent HBeAg positivity in patients with chronic hepatitis B treated with nucleos(t)ide analogues
Conclusion: HBeAg-positive patients with chronic hepatitis B have persistent HBeAg positivity when treated with long-term nucleos(t)ide analogues. Accordingly, a greater proportion of this kind of patient family and mothers have a remarkable history of hepatitis B and a reduced HBV DNA relapse rate in the early stages (within a year or less).PMID:38584099 | DOI:10.3760/cma.j.cn501113-20230822-00065 (Source: Cancer Control)
Source: Cancer Control - April 7, 2024 Category: Cancer & Oncology Authors: L P Peng W Q Gan Y B Zheng Y M Chen J Liu Z B Wu Z L Gao Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Cancer Control)
Source: Cancer Control - April 7, 2024 Category: Cancer & Oncology Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
CONCLUSION: Reduced DNmDCs and impaired maturation may be associated with the onset of the plateau phase during intermittent interferon therapy in patients with chronic hepatitis B.PMID:38582994 | DOI:10.3967/bes2024.033 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Liu Yang Shi Yu Wang Ting Ting Jiang Wen Deng Min Chang Shu Ling Wu Wei Hua Cao Yao Lu Ge Shen Ru Yu Liu Yuan Jiao Gao Meng Jiao Xu Lei Ping Hu Lu Zhang Yao Xie Ming Hui Li Source Type: research
Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model
CONCLUSION: Combination therapy of anti-hOX40 and HBc VLPs provides synergistic antitumor activity in colon cancer-bearing mice, which may represent a potential design strategy for cancer immunotherapy.PMID:38582981 | DOI:10.3967/bes2024.019 (Source: Biomedical and Environmental Sciences : BES)
Source: Biomedical and Environmental Sciences : BES - April 7, 2024 Category: Biomedical Science Authors: Jia Jia Liu Qiu Dong Su Yao Yi Li Ping Shen Sheng Li Bi Source Type: research
